Ocrevus Zunovo for MS: Mixed Methods

Part of paid clinical trials in Chicago, Illinois.

Sponsor
Northwestern University
Study ID
NCT07710105
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Clinical Questionnaires — OTHER
    Clinical course will be followed, including retention in treatment, patient-reported outcomes, and clinical events (new or incident demyelinating lesions on MRI or disease attacks).
  • Semi-Structured Interviews — OTHER
    Semi-structured interviews will be conducted using an interview guide. Interviews will be audio-recorded, transcribed, and documented via field notes.

Study Details

Ocrevus Zunovo implementation, feasibility, acceptability, patient satisfaction, treatment persistence, and impact on MS disease outcomes will be analyzed in this mixed methods study. This study will incorporate clinical data and questionnaire results from MS patients who take Ocrevus Zunovo as well as qualitative interviews with MS patients, family members, and other individuals involved in Ocrevus Zunovo treatment. The purpose of this study is to synthesize implementation strategies that improve patient access to high-efficacy MS therapies in real-world settings.

Key Dates

First listed
Jul 17, 2026
Start date
Jun 12, 2026
Status verified
Jul 2026
Primary completion
Dec 31, 2028
Completion
Dec 31, 2028

Study Design

Enrollment
150 participants (estimated)

Arms

  • Arm: Clinical Arm
    All enrolled OZ-treated MS participants will have at least one clinical inpatient visit at Northwestern Medicine.
  • Arm: Interview Arm
    Interviews (with record taking) will take up to 2 hours to discuss barriers and facilitators to the administration of OZ.

Primary Outcome Measure

Patient Satisfaction and Treatment Persistence [ Time Frame: From enrollment to 12-month follow-up visit ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Northwestern Memorial HospitalChicagoIllinois60611
Dylan Rice, B.A.
[email protected]
312-503-5298
Audrey Chang, B.A.
[email protected]
312-503-8639
Farrah J Mateen, MD, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Chicago, IL

By condition
Multiple sclerosis
By specialty
NeurologyBrain disordersAutoimmune disease
By research site
Northwestern Memorial Hospital· Chicago, IL

Related Studies